Sofia Azambuja Braga
Impact in
- Cancer Research top 2%
- Breast Cancer Treatment Studies
- Oncology top 2%
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 29
- HER2/EGFR in Cancer Research 17
- Cancer Immunotherapy and Biomarkers 5
- Colorectal Cancer Treatments and Studies 3
- Colorectal Cancer Surgical Treatments 2
-
- Breast Cancer Treatment Studies 14
- Co-authors
- António Jacinto (5 shared papers)Maria Guadalupe Cabral (5 shared papers)Diana P. Saraiva (5 shared papers)Marta Vaz Batista (15 shared papers)Martine J Piccart (4 shared papers)José Luís Passos‐Coelho (3 shared papers)Ahmad Hussein Awada (2 shared papers)Fátima Cardoso (5 shared papers)
In The Last Decade
Sofia Azambuja Braga
57 papers receiving 3.3k citations
Sofia Azambuja Braga's Hit Papers
Peers
Comparison fields: 5 of 106
- Cancer Research 817
- Oncology 1.1k
- Pulmonary and Respiratory Medicine 717
- Public Health, Environmental and Occupational Health 228
- Reproductive Medicine 63
Countries citing papers authored by Sofia Azambuja Braga
This map shows the geographic impact of Sofia Azambuja Braga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofia Azambuja Braga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofia Azambuja Braga more than expected).
Fields of papers citing papers by Sofia Azambuja Braga
This network shows the impact of papers produced by Sofia Azambuja Braga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofia Azambuja Braga. The network helps show where Sofia Azambuja Braga may publish in the future.
Co-authors
The 25 scholars most cited alongside Sofia Azambuja Braga, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer Hit paper breakdown → | 2019 | 992 |
| 2 | Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer Hit paper breakdown → | 2022 | 329 |
| 3 | 2013 | 318 | |
| 4 | 2018 | 233 | |
| 5 | Trastuzumab deruxtecan in patients with central nervous system involvement from HER2-positive breast cancer: The DEBBRAH trial Hit paper breakdown → | 2022 | 210 |
| 6 | 2006 | 200 | |
| 7 | 2007 | 94 | |
| 8 | 2021 | 93 | |
| 9 | 2011 | 67 | |
| 10 | 2020 | 65 | |
| 11 | 2024 | 60 | |
| 12 | 2008 | 59 | |
| 13 | 2006 | 58 | |
| 14 | 2011 | 57 | |
| 15 | 2018 | 56 | |
| 16 | 2017 | 51 | |
| 17 | 2017 | 44 | |
| 18 | 2021 | 40 | |
| 19 | 2022 | 36 | |
| 20 | 2021 | 31 |
About Sofia Azambuja Braga
Sofia Azambuja Braga is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Obstetrics and Gynecology and Reproductive Medicine, having authored 60 papers that have together received 3.4k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (17 papers), Breast Cancer Treatment Studies (14 papers), Brain Metastases and Treatment (11 papers), Cancer Immunotherapy and Biomarkers (5 papers), Advanced Breast Cancer Therapies (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Endometrial and Cervical Cancer Treatments (2 papers) and Colorectal Cancer Surgical Treatments (2 papers). The work is most often cited by research in Cancer Research (817 citations), Oncology (1.1k citations), Pulmonary and Respiratory Medicine (717 citations), Public Health, Environmental and Occupational Health (228 citations) and Reproductive Medicine (63 citations). Sofia Azambuja Braga has collaborated with scholars based in Portugal, Spain and Belgium. Frequent co-authors include António Jacinto, Maria Guadalupe Cabral, Diana P. Saraiva, Marta Vaz Batista, Martine J Piccart, José Luís Passos‐Coelho, Ahmad Hussein Awada, Fátima Cardoso, Paula Borralho and Javier Cortés. Their work appears in journals such as ESMO Open, Annals of Oncology, Journal of Clinical Oncology, Frontiers in Oncology and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.